Skip to main content
OpenTrials
Completed

NCT Number: NCT00997256

Study to Investigate Effects of a Herbal Drug Compared to Placebo on Sleep

To demonstrate the influence of a herbal preparation containing hypericum, passionflower, and valerian on sleep structure, improvement of attention, and well-being in comparison to placebo.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–55 year

Sex eligibility

Male

Study type

Interventional

Phase

Phase 1

Primary location

Phillipps University, Clinic for Psychiatry and Psychotherapy

Marburg, Hesse, 35039, Germany

About this study

To demonstrate the influence of the herbal combination preparation Neurapas® balance on the objective sleep structure in comparison with placebo. A further aim was to investigate whether treatment with Neurapas® balance versus placebo brings about an improvement in attention and well-being and whether these changes are related to the improvement in the sleep structure.

  • Does the administration of 3 x 2 Neurapas® balance tablets over a period of three days vs. placebo lead to an improvement in continuity of sleep?
  • Does the administration of 3 x 2 Neurapas® balance tablets over a period of three days vs. placebo lead to an improvement in sleep architecture, especially an increase in deep sleep?
  • Does the administration of 3 x 2 Neurapas® balance tablets over a period of three days vs. placebo lead to an improvement in morning attentional performance?
  • Does the administration of 3 x 2 Neurapas® balance tablets over a period of three days vs. placebo lead to an improvement in morning well-being?

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Healthy male volunteers aged between 18 and 55 years
  • Normal sleeping times (at least 6 hours a night), going to sleep between 22.00 and 1.00 hours, getting up between 6.00 and 9.00 hours
  • Written informed consent
  • The volunteer is willing and able to cooperate fully
  • The volunteer agrees not to drink any alcohol for the duration of the study

Exclusion criteria

  • Participation in another study in the last 30 days or participation in this study at an earlier date
  • Lack of verbal or intellectual ability to communicate adequately and to understand the information to volunteers
  • Legal incompetence
  • Smoker
  • Shift worker
  • Transatlantic flight in the last 4 weeks
  • Taking psychotropic drugs within the last 4 weeks
  • Taking medicines that influence the EEG within the last 4 weeks
  • Diseases that influence the sleep EEG
  • History of known medication / drug / alcohol misuse according to ICD-10 coding F10 - F19
  • Known intolerance/hypersensitivity/allergy to St. John's wort, valerian or passionflower
  • Taking inadmissible concomitant medication (anxiolytic, neuroleptic or hypnotic drugs, cyclosporin, sedative, sleep-promoting or mood-enhancing medicines, antidepressants other than the trial medication, coumarin-type anticoagulants, oral contraceptives, tranquillisers, homeopathic remedies, digoxin, theophylline, indinavir, nortriptyline, amitriptyline)
  • Known light-sensitivity

Treatment and study plan

Neurapas® balance (Herbal product (Hypericum, Passionflower, Valerian))

Drug

3 x 2 tablets / day over 3 days

Other names: Neurapas balance, film-coated tablet over 3 days

film-coated sugar-pill

Drug

3 x 2 tablets / day over 3 days

Primary outcomes

  1. Evaluation of sleep by Polysomnography (sleep continuity and sleep architecture)

    Time frame: Day 3 + 14

Secondary outcomes

  1. Attention Stress Test d2 (Brickenkamp)

    Time frame: Day 4 + 15

  2. Alertness and vigilance test (TAP)

    Time frame: Day 4 + 15

  3. Trail-Making Test (TMT)

    Time frame: Day 4 + 15

  4. Questionnaire on physical symptoms of subjective well-Being(MKSL, Janke)

    Time frame: Day 4 +15

  5. Questionnaire on psychological aspects of well-being(BSKE, Janke)

    Time frame: Day 4 + 15

  6. ZERSSEN Scale of evaluation of subjective well-being (Bf-S)

    Time frame: Day 4 + 15

  7. Sleep Questionnaire(SF)

    Time frame: Day 4 + 15

Sponsors and collaborators

Lead sponsor

Pascoe Pharmazeutische Praeparate GmbH

Industry

Registry information

Official study title

Phase I, Placebo-controlled, Double-blind, Randomised, Single-centre Study of Single Cross-over Design to Investigate the Effects of the Herbal Preparation Neurapas® Balance Compared With Placebo on Sleep EEG, Mental Performance and Well-being

Acronym: sleep-EEG

Important dates

Study start
2004
Primary completion
2005
Study completion
2005
First posted
Oct 19, 2009
Registry last updated
May 17, 2010

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.